Manufacturer

Strengthening Enforcement against Unauthorized Promotion and Distribution of GLP-1 Based Drugs

Posted by: Prabhas Chakraborty May 22, 2026

What's New 2?

Regulation/Guidelines

80 Categories, One Product: How to Get Cosmetic Product Categorisation Right in India

The Categorisation Problem Of all the challenges in India's Cosmetic Import registration process, product categorisation is one of the most underestimated. Under the Cosmetics Rules, 2020, CDSCO has prescribed 80...

3rd June, 2026

Regulation/Guidelines

Authorized Agent for Medical Device Import in India: When You Need One and How to Choose the Right Partner

For foreign Medical Device companies entering India, the authorized agent is not just a compliance checkpoint — it is a strategic regulatory role. The right appointment can support licensing procedure,...

2nd June, 2026

Regulation/Guidelines

How to Obtain CDSCO Approval for Biosimilars in India: Complete 2026 Regulatory Pathway

Why India Demands a Dedicated Biosimilar Strategy India is one of the fastest-growing Biosimilar markets in the world, driven by a large patient population, expanding government healthcare coverage under Ayushman...

29th May, 2026

Regulation/Guidelines

Why Pharmaceutical Manufacturers Fail Regulatory Due Diligence Before Acquisition

Pharmaceutical acquisitions are complex, high-stakes transactions. Financial modelling, commercial valuation, and market positioning typically receive the most intensive scrutiny. Yet the most consequential risks in many transactions are neither financial...

28th May, 2026

Manufacturer

Manufacturer

Advisory regarding implementation of recommendations of the High-Level Committee constituted by NITI Aayog on Non-Financial Regulatory Reforms reg

Final FSS (Contaminants, Toxins and Residues) amendment Regulations, 2026 relating to provision of metal contaminants, naturally occurring toxic substances, and antibiotic residues

Draft Food Safety and Standards (Food Products Standards and Food Additives) Amendment Regulations, 2026 relating to Minor seed oils, Edible seeds and Appendix A

Revised Regulatory Guidelines For Sampling Of Drugs, Cosmetics & Medical Devices By Drugs Inspectors Of Central & State Drug Authorities

BE-NOC Prior Intimation (System of Notification for certain category of new drugs for conduct of “BA-BE Studies” for export purpose under Chapter V, NDCT Rule, 2019) and procedure for obtaining CT-16 application on NSWS Portal

2026.05.13 G.S.R. 377(E)_Notification for amendment in Schedule H1 for inclusion of Pregabalin and its drug formulations

Use of Customary Units as Supplementary Statements alongside Standard Units under the Legal Metrology Framework – reg.

Strengthening Enforcement against Unauthorized Promotion and Distribution of GLP-1 Based Drugs

For Importers To India

Drug

Biologicals

Food Supplements

Medical Device

IVD

Food

Cosmetic

Other

For Manufacturer in India

Drug

Biologicals

Food Supplements

Food

Medical Device

IVD

Cosmetic

Other